Associations between brain‐derived neurotrophic factor and cognitive impairment in panic disorder
Authors:
Open Access
- 12 October 2020
- journal article
- research article
- Published by Wiley in Brain and Behavior
- Vol. 10 (12) , e01885
Abstract
Introduction: Our study was designed to examine the relationship between Brain‐Derived Neurotrophic Factor (BDNF) genotypes (rs6265, Val66Met), BDNF plasma levels, and cognitive impairment in Chinese patients with panic disorder (PD).Methods: Total 85 patients with PD and 91 healthy controls finally completed all assessments. The severity of panic symptoms and whole anxiety of PD was measured by Panic Disorder Severity Scale–Chinese Version (PDSS‐CV) and Hamilton Anxiety Scale (HAMA‐14). Montreal Cognitive Assessment (MoCA) and some neurocognitive measures were conducted to evaluate the cognitive performance. All participants were detected for the plasma BDNF levels and BDNF Val66Met polymorphism before assessment and treatment.Results: No significant differences were found in the BDNF allele frequencies and the BDNF genotype distributions between healthy controls and PD patients. BDNF Met/Met genotype was associated with lower BDNF plasma levels in PD patients, and PD patients with BDNF Met/Met genotype had the lower scores in the attention and speed of processing domains compared to those with Val/Val and Met/Val genotype (p's < .05). Among PD patients, the BDNF plasma levels showed moderate positive correlations with Stroop interference (r = .60, p < .001). Using the MoCA data, the BDNF plasma levels were correlated with delayed memory (r = .50, p < .001), verbal learning (r = .45, p < .001), and total scores of MoCA (r = .51, p < .001).Conclusions: The BDNF Met/Met genotype may be associated with lower BDNF plasma levels and cognitive impairments in PD patients.Keywords
This publication has 47 references indexed in Scilit:
- Identification and medical utilization of newly diagnosed panic disorder: A Nationwide case–control studyJournal of Psychosomatic Research, 2019
- Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysisPsychological Medicine, 2019
- The brain‐derived neurotrophic factor VAL68MET polymorphism modulates how developmental ethanol exposure impacts the hippocampusGenes, Brain and Behavior, 2018
- Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier PatientsNeuropsychobiology, 2017
- Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive ImpairmentJournal of the American Geriatrics Society, 2016
- Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met alleleJournal of Affective Disorders, 2016
- Brain-derived neurotrophic factor serum levels in genetically isolated populations: gender-specific association with anxiety disorder subtypes but not with anxiety levels or Val66Met polymorphismPeerJ, 2015
- Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disordersJournal of Psychiatric Research, 2014
- Cognitive functions in patients with panic disorder: a literature reviewBrazilian Journal of Psychiatry, 2013
- VAL66MET BDNF GENOTYPES IN MELANCHOLIC DEPRESSION: EFFECTS ON BRAIN STRUCTURE AND TREATMENT OUTCOMEDepression and Anxiety, 2012